
IndraLab
Statements
reach
"Therefore, the effects of dextromethorphan on the dysfunction of other affected organs remain to be investigated.In conclusion, although the role of SIGMAR1 has emerged in various diseases including neurological disorders and cancer and more recently cardiovascular diseases and COVID-19 , our findings demonstrate that SIGMAR1 could be a therapeutic target for TS and potentially LQTS1 and LQTS2 caused by the G269S mutation in K 7.1 channel and the A561V mutation in hERG channel, respectively."